Jun Yang

Medicine & Life Sciences

1. Pulmonary Arterial Hypertension 100%
2. hepatoma-derived growth factor 75%
3. Pulmonary Hypertension 48%
4. Endostatins 39%
5. Biomarkers 35%
6. Angiostatic Proteins 27%
7. Neurogranin 24%
8. Survival 24%
9. Pediatrics 21%
10. Insulin-Like Growth Factor Binding Protein 2 19%
11. Interleukin-6 16%
12. Serum 14%
13. Proteomics 13%
14. insulin-like growth factor binding protein-related protein 1 13%
15. Lung Diseases 13%
16. Pulmonary Artery 13%
17. Insulin-Like Growth Factor Binding Proteins 12%
18. Galectin 4 12%
19. MYND Domains 12%
20. Human immunodeficiency virus 1 gp120 protein 12%
21. cyclohexanone 11%
22. C-terminal binding protein 11%
23. Enzyme-Linked Immunosorbent Assay 11%
24. Perinatology 10%
25. Insulin-Like Growth Factor Binding Protein 4 10%
26. PR-SET Domains 10%
27. Lung 10%
28. pro-brain natriuretic peptide (1-76) 9%
29. Leukocyte L1 Antigen Complex 9%
30. Vascular Remodeling 9%
31. Proteins 8%
32. Fatty Acid-Binding Proteins 8%
33. Citrulline 8%
34. Child 8%
35. Mortality 8%
36. Phenotype 8%
37. Smooth Muscle Myocytes 7%
38. Chemotactic Factors 7%
39. Vascular Resistance 7%
40. Somatomedins 7%
41. Parkinsonian Disorders 7%
42. Sickle Cell Anemia 7%
43. Environmental Exposure 7%
44. Brain Injuries 7%
45. Down Syndrome 7%
46. Conditioned Culture Medium 6%
47. Mitogens 6%
48. Traumatic Brain Injury 6%
49. Carrier Proteins 6%